Literature DB >> 21594304

Metabolic tumour volume. Prognostic value in locally advanced squamous cell carcinoma of the head and neck.

P Deron1, K Mertens, I Goethals, S Rottey, F Duprez, W De Neve, H Vermeersch, C Van de Wiele.   

Abstract

PURPOSE: Evaluate the predictive and prognostic value of semi-quantitative FDG-PET variables derived from pretreatment FDG-PET images in patients suffering from locally advanced squamous cell carcinoma of the head and neck (SCCHN), treated by means of concomitant radiochemotherapy. PATIENTS,
METHODS: 40 patients with newly diagnosed SCCHN that were treated with concomitant radiochemotherapy underwent FDG-PET/CT for treatment planning; 18 patients had neck dissection prior to their baseline scan and to receiving radiochemotherapy. FDG-PET images were used to calculate metabolic tumour volumes using region growing and a threshold of 50% (MTV50) of primary lesions and involved lymph nodes as well as the mean and maximum standard uptake value (SUVmean and SUVmax) of the primary tumours.
RESULTS: Neither SUVmean nor SUVmax values of the primary tumour were significantly different between responders and non-responders whereas MTV50 values of the primary tumour proved significantly higher in non-responders. SUVmean, SUVmax and MTV50 of the primary tumour were not predictive for overall or disease free survival. Contrariwise, dichotomized summed MTV50 values (cut-off≥31 cm3) of the primary tumour and involved lymph nodes in patients that didn't have neck dissection prior to radiochemotherapy were predictive for disease free and overall survival in both univariate and multivariate analysis (p≤0.05).
CONCLUSION: Summed MTV50 values of both the primary tumour and involved lymph nodes provided independent prognostic information on disease free and overall survival.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21594304     DOI: 10.3413/Nukmed-0367-10-11

Source DB:  PubMed          Journal:  Nuklearmedizin        ISSN: 0029-5566            Impact factor:   1.379


  5 in total

1.  The relative prognostic utility of standardized uptake value, gross tumor volume, and metabolic tumor volume in oropharyngeal cancer patients treated with platinum based concurrent chemoradiation with a pre-treatment [(18)F] fluorodeoxyglucose positron emission tomography scan.

Authors:  Paul B Romesser; Remy Lim; Daniel E Spratt; Jeremy Setton; Nadeem Riaz; Benjamin Lok; Shyam Rao; Eric J Sherman; Heiko Schöder; Nancy Y Lee
Journal:  Oral Oncol       Date:  2014-07-17       Impact factor: 5.337

2.  Robustness of intratumour ¹⁸F-FDG PET uptake heterogeneity quantification for therapy response prediction in oesophageal carcinoma.

Authors:  Mathieu Hatt; Florent Tixier; Catherine Cheze Le Rest; Olivier Pradier; Dimitris Visvikis
Journal:  Eur J Nucl Med Mol Imaging       Date:  2013-07-16       Impact factor: 9.236

3.  Predictive and prognostic value of metabolic tumour volume and total lesion glycolysis in solid tumours.

Authors:  Christophe Van de Wiele; Vibeke Kruse; Peter Smeets; Mike Sathekge; Alex Maes
Journal:  Eur J Nucl Med Mol Imaging       Date:  2012-11-14       Impact factor: 9.236

4.  Impact of PET reconstruction protocols on quantification of lesions that fulfil the PERCIST lesion inclusion criteria.

Authors:  Joke Devriese; Laurence Beels; Alex Maes; Christophe Van de Wiele; Hans Pottel
Journal:  EJNMMI Phys       Date:  2018-12-07

5.  Total lesion glycolysis in oral squamous cell carcinoma as a biomarker derived from pre-operative FDG PET/CT outperforms established prognostic factors in a newly developed multivariate prediction model.

Authors:  Gerrit Spanier; Daniela Weidt; Dirk Hellwig; Johannes K H Meier; Torsten E Reichert; Jirka Grosse
Journal:  Oncotarget       Date:  2021-01-05
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.